Related Experiment Video
Updated: Aug 18, 2026

Ultrasound Based Assessment of Coronary Artery Flow and Coronary Flow Reserve Using the Pressure Overload Model in Mice
Published on: April 13, 2015
Response of the coronary vasculature to myocardial hypertrophy
1Department of Anatomy, University of Iowa, Iowa City 52242.
Insights
Cardiac hypertrophy can impair blood flow due to vessel growth issues. Some models show angiogenesis, suggesting blood flow and diastolic duration may stimulate new vessel growth in the heart.
Area of Science:
- Cardiovascular Physiology
- Cardiac Pathophysiology
- Vascular Biology
Background:
- Cardiac hypertrophy often involves myocardial perfusion abnormalities, including reduced coronary reserve and subendocardial underperfusion.
- These deficits arise from inadequate growth of coronary resistance vessels or luminal narrowing due to vessel wall changes.
- However, not all hypertrophy models exhibit perfusion deficits, with some showing significant arteriolar and capillary growth.
Purpose of the Study:
- To explore the anatomic variables contributing to perfusion deficits in cardiac hypertrophy.
- To investigate the role of angiogenesis in different models of cardiac hypertrophy.
- To examine the potential stimuli for coronary angiogenesis, such as increased blood flow and diastolic duration.
Main Methods:
- Review of existing literature on cardiac hypertrophy and myocardial perfusion.
- Analysis of experimental studies investigating coronary vascular adaptation.
- Examination of factors influencing angiogenesis in hypertrophied hearts.
Main Results:
- Perfusion deficits are linked to disproportionate vessel growth and luminal narrowing (medial hypertrophy, hyperplasia, fibrosis).
- Exercise- and thyroxine-induced hypertrophy models demonstrate substantial arteriolar and capillary proliferation.
- Angiogenesis is observed in some hypertrophy models, particularly with sufficient duration, supporting stimulation by blood flow or prolonged diastole.
Conclusions:
- The interplay between vessel growth, luminal diameter, and angiogenesis is complex in cardiac hypertrophy.
- Increased blood flow and prolonged diastole are potential triggers for coronary angiogenesis.
- Further research is needed to fully elucidate the mechanisms and variables governing angiogenesis in various hypertrophy models.
Abstract:
Cardiac hypertrophy is often characterized by abnormalities in myocardial perfusion, including decreased coronary reserve, increased minimal coronary vascular resistance, underperfusion of the subendomyocardium during conditions of high oxygen demand and increased risk of infarction in the presence of coronary occlusion. Two major anatomic variables may cause these perfusion deficits. First, the coronary resistance vessels may not grow in proportion to the magnitude of the cardiac enlargement. Second, the luminal diameter of resistance vessels may become reduced as a consequence of medial hypertrophy, hyperplasia or fibrosis. A luminal narrowing coupled with a lack or inadequate numeric proliferation of resistance vessels can markedly limit maximal myocardial perfusion. However, not all models of cardiac hypertrophy are characterized by perfusion abnormalities. A substantial growth of arterioles and capillaries has been documented in exercise- and thyroxine-induced left ventricular hypertrophy. Moreover, at least in some models, angiogenesis occurs when the duration of the ventricular hypertrophy is sufficient. The hypothesis that coronary angiogenesis is stimulated by increased blood flow or prolongation of diastole appears to have support from a number of experimental studies. However, the cascade of events underlying angiogenesis and the numerous variables that characterize the various models of hypertrophy are complex and require elucidation.
Related Concept Videos
Pathophysiology of Cardiac Performance
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Myocarditis I: Introduction
Heart Failure II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cellular Adaptation II: Hypertrophy

